Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Kronos Bio Inc stock

Learn how to easily invest in Kronos Bio Inc stock.

Kronos Bio Inc is a biotechnology business based in the US. Kronos Bio Inc shares (KRON) are listed on the NASDAQ and all prices are listed in US Dollars. Kronos Bio Inc employs 96 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Kronos Bio Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KRON – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Kronos Bio Inc stock price (NASDAQ: KRON)

Use our graph to track the performance of KRON stocks over time.

Kronos Bio Inc shares at a glance

Information last updated 2022-06-24.
Latest market close$3.74
52-week range$2.96 - $25.76
50-day moving average $4.25
200-day moving average $10.93
Wall St. target price$22.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.92

Buy Kronos Bio Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
Financial advice powered by relationships, not commissions.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kronos Bio Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kronos Bio Inc price performance over time

Historical closes compared with the close of $3.74 from 2022-06-29

1 week (2022-06-23) 4.47%
1 month (2022-06-01) 8.41%
3 months (2022-04-01) -49.12%
6 months (2021-12-31) -72.48%
1 year (2021-07-01) -84.63%
2 years (2020-06-27) N/A
3 years (2019-06-27) N/A
5 years (2017-06-27) N/A

Kronos Bio Inc financials

Gross profit TTM $0
Return on assets TTM -23.66%
Return on equity TTM -42.31%
Profit margin 0%
Book value $5.66
Market capitalisation $203.1 million

TTM: trailing 12 months

Kronos Bio Inc share dividends

We're not expecting Kronos Bio Inc to pay a dividend over the next 12 months.

Have Kronos Bio Inc's shares ever split?

Kronos Bio Inc's shares were split on a 3:2 basis on 2 November 2003. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Kronos Bio Inc shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Kronos Bio Inc shares which in turn could have impacted Kronos Bio Inc's share price.

Kronos Bio Inc overview

Kronos Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.

Frequently asked questions

What percentage of Kronos Bio Inc is owned by insiders or institutions?
Currently 15.545% of Kronos Bio Inc shares are held by insiders and 66.587% by institutions.
How many people work for Kronos Bio Inc?
Latest data suggests 96 work at Kronos Bio Inc.
When does the fiscal year end for Kronos Bio Inc?
Kronos Bio Inc's fiscal year ends in December.
Where is Kronos Bio Inc based?
Kronos Bio Inc's address is: 1300 South El Camino Real, San Mateo, CA, United States, 94402
What is Kronos Bio Inc's ISIN number?
Kronos Bio Inc's international securities identification number is: US50107A1043
What is Kronos Bio Inc's CUSIP number?
Kronos Bio Inc's Committee on Uniform Securities Identification Procedures number is: 501052104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site